Tamoxifen Treatment Ameliorates Contractile Dysfunction of Duchenne Muscular Dystrophy Stem Cell-Derived Cardiomyocytes on Bioengineered Substrates

To examine the effects of chronic 4-hydroxytamoxifen treatment, researchers used state-of-the-art human-induced pluripotent stem cell-derived cardiomyocytes and a bioengineered platform to model duchenne muscular dystrophy.